Global Cardiology Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030
Page: 121
Published Date: 04 Mar 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Cardiology Radiopharmaceuticals market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Cardiology Radiopharmaceuticals demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cardiology Radiopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiology Radiopharmaceuticals that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cardiology Radiopharmaceuticals total market, 2019-2030, (USD Million)
Global Cardiology Radiopharmaceuticals total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cardiology Radiopharmaceuticals total market, key domestic companies and share, (USD Million)
Global Cardiology Radiopharmaceuticals revenue by player and market share 2019-2024, (USD Million)
Global Cardiology Radiopharmaceuticals total market by Type, CAGR, 2019-2030, (USD Million)
Global Cardiology Radiopharmaceuticals total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Cardiology Radiopharmaceuticals market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Cardinal Health, Curium Pharma, Lantheus Medical Imaging, Inc., Eczacıbaşı Monrol Nuclear Products, Novartis International AG, Siemens, China Isotope & Radiation and Yantai Dongcheng Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cardiology Radiopharmaceuticals market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Cardiology Radiopharmaceuticals Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Cardiology Radiopharmaceuticals Market, Segmentation by Type
Technetium-99
Fluorine-18
Gallium-67
Others
Global Cardiology Radiopharmaceuticals Market, Segmentation by Application
Therapeutic Use
Diagnostic Use
Companies Profiled:
GE Healthcare
Cardinal Health
Curium Pharma
Lantheus Medical Imaging, Inc.
Eczacıbaşı Monrol Nuclear Products
Novartis International AG
Siemens
China Isotope & Radiation
Yantai Dongcheng Pharmaceutical
Jubilant Life Sciences
Bracco
Key Questions Answered
1. How big is the global Cardiology Radiopharmaceuticals market?
2. What is the demand of the global Cardiology Radiopharmaceuticals market?
3. What is the year over year growth of the global Cardiology Radiopharmaceuticals market?
4. What is the total value of the global Cardiology Radiopharmaceuticals market?
5. Who are the major players in the global Cardiology Radiopharmaceuticals market?
Table of Contents
1 Supply Summary
1.1 Cardiology Radiopharmaceuticals Introduction
1.2 World Cardiology Radiopharmaceuticals Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Cardiology Radiopharmaceuticals Total Market by Region (by Headquarter Location)
1.3.1 World Cardiology Radiopharmaceuticals Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Cardiology Radiopharmaceuticals Market Size (2019-2030)
1.3.3 China Cardiology Radiopharmaceuticals Market Size (2019-2030)
1.3.4 Europe Cardiology Radiopharmaceuticals Market Size (2019-2030)
1.3.5 Japan Cardiology Radiopharmaceuticals Market Size (2019-2030)
1.3.6 South Korea Cardiology Radiopharmaceuticals Market Size (2019-2030)
1.3.7 ASEAN Cardiology Radiopharmaceuticals Market Size (2019-2030)
1.3.8 India Cardiology Radiopharmaceuticals Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cardiology Radiopharmaceuticals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cardiology Radiopharmaceuticals Major Market Trends
2.1 World Cardiology Radiopharmaceuticals Consumption Value (2019-2030)
2.2 World Cardiology Radiopharmaceuticals Consumption Value by Region
2.2.1 World Cardiology Radiopharmaceuticals Consumption Value by Region (2019-2024)
2.2.2 World Cardiology Radiopharmaceuticals Consumption Value Forecast by Region (2025-2030)
2.3 United States Cardiology Radiopharmaceuticals Consumption Value (2019-2030)
2.4 China Cardiology Radiopharmaceuticals Consumption Value (2019-2030)
2.5 Europe Cardiology Radiopharmaceuticals Consumption Value (2019-2030)
2.6 Japan Cardiology Radiopharmaceuticals Consumption Value (2019-2030)
2.7 South Korea Cardiology Radiopharmaceuticals Consumption Value (2019-2030)
2.8 ASEAN Cardiology Radiopharmaceuticals Consumption Value (2019-2030)
2.9 India Cardiology Radiopharmaceuticals Consumption Value (2019-2030)
3.1 World Cardiology Radiopharmaceuticals Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cardiology Radiopharmaceuticals Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cardiology Radiopharmaceuticals in 2023
3.2.3 Global Concentration Ratios (CR8) for Cardiology Radiopharmaceuticals in 2023
3.3 Cardiology Radiopharmaceuticals Company Evaluation Quadrant
3.4 Cardiology Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.4.1 Cardiology Radiopharmaceuticals Market: Region Footprint
3.4.2 Cardiology Radiopharmaceuticals Market: Company Product Type Footprint
3.4.3 Cardiology Radiopharmaceuticals Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4.1 United States VS China: Cardiology Radiopharmaceuticals Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cardiology Radiopharmaceuticals Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Cardiology Radiopharmaceuticals Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Cardiology Radiopharmaceuticals Consumption Value Comparison
4.2.1 United States VS China: Cardiology Radiopharmaceuticals Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Cardiology Radiopharmaceuticals Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Cardiology Radiopharmaceuticals Companies and Market Share, 2019-2024
4.3.1 United States Based Cardiology Radiopharmaceuticals Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cardiology Radiopharmaceuticals Revenue, (2019-2024)
4.4 China Based Companies Cardiology Radiopharmaceuticals Revenue and Market Share, 2019-2024
4.4.1 China Based Cardiology Radiopharmaceuticals Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cardiology Radiopharmaceuticals Revenue, (2019-2024)
4.5 Rest of World Based Cardiology Radiopharmaceuticals Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Cardiology Radiopharmaceuticals Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cardiology Radiopharmaceuticals Revenue, (2019-2024)
5.1 World Cardiology Radiopharmaceuticals Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Technetium-99
5.2.2 Fluorine-18
5.2.3 Gallium-67
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Cardiology Radiopharmaceuticals Market Size by Type (2019-2024)
5.3.2 World Cardiology Radiopharmaceuticals Market Size by Type (2025-2030)
5.3.3 World Cardiology Radiopharmaceuticals Market Size Market Share by Type (2019-2030)
6.1 World Cardiology Radiopharmaceuticals Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Therapeutic Use
6.2.2 Diagnostic Use
6.3 Market Segment by Application
6.3.1 World Cardiology Radiopharmaceuticals Market Size by Application (2019-2024)
6.3.2 World Cardiology Radiopharmaceuticals Market Size by Application (2025-2030)
6.3.3 World Cardiology Radiopharmaceuticals Market Size by Application (2019-2030)
7.1 GE Healthcare
7.1.1 GE Healthcare Details
7.1.2 GE Healthcare Major Business
7.1.3 GE Healthcare Cardiology Radiopharmaceuticals Product and Services
7.1.4 GE Healthcare Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 GE Healthcare Recent Developments/Updates
7.1.6 GE Healthcare Competitive Strengths & Weaknesses
7.2 Cardinal Health
7.2.1 Cardinal Health Details
7.2.2 Cardinal Health Major Business
7.2.3 Cardinal Health Cardiology Radiopharmaceuticals Product and Services
7.2.4 Cardinal Health Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Cardinal Health Recent Developments/Updates
7.2.6 Cardinal Health Competitive Strengths & Weaknesses
7.3 Curium Pharma
7.3.1 Curium Pharma Details
7.3.2 Curium Pharma Major Business
7.3.3 Curium Pharma Cardiology Radiopharmaceuticals Product and Services
7.3.4 Curium Pharma Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Curium Pharma Recent Developments/Updates
7.3.6 Curium Pharma Competitive Strengths & Weaknesses
7.4 Lantheus Medical Imaging, Inc.
7.4.1 Lantheus Medical Imaging, Inc. Details
7.4.2 Lantheus Medical Imaging, Inc. Major Business
7.4.3 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Product and Services
7.4.4 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Lantheus Medical Imaging, Inc. Recent Developments/Updates
7.4.6 Lantheus Medical Imaging, Inc. Competitive Strengths & Weaknesses
7.5 Eczacıbaşı Monrol Nuclear Products
7.5.1 Eczacıbaşı Monrol Nuclear Products Details
7.5.2 Eczacıbaşı Monrol Nuclear Products Major Business
7.5.3 Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Product and Services
7.5.4 Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Eczacıbaşı Monrol Nuclear Products Recent Developments/Updates
7.5.6 Eczacıbaşı Monrol Nuclear Products Competitive Strengths & Weaknesses
7.6 Novartis International AG
7.6.1 Novartis International AG Details
7.6.2 Novartis International AG Major Business
7.6.3 Novartis International AG Cardiology Radiopharmaceuticals Product and Services
7.6.4 Novartis International AG Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Novartis International AG Recent Developments/Updates
7.6.6 Novartis International AG Competitive Strengths & Weaknesses
7.7 Siemens
7.7.1 Siemens Details
7.7.2 Siemens Major Business
7.7.3 Siemens Cardiology Radiopharmaceuticals Product and Services
7.7.4 Siemens Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Siemens Recent Developments/Updates
7.7.6 Siemens Competitive Strengths & Weaknesses
7.8 China Isotope & Radiation
7.8.1 China Isotope & Radiation Details
7.8.2 China Isotope & Radiation Major Business
7.8.3 China Isotope & Radiation Cardiology Radiopharmaceuticals Product and Services
7.8.4 China Isotope & Radiation Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 China Isotope & Radiation Recent Developments/Updates
7.8.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.9 Yantai Dongcheng Pharmaceutical
7.9.1 Yantai Dongcheng Pharmaceutical Details
7.9.2 Yantai Dongcheng Pharmaceutical Major Business
7.9.3 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product and Services
7.9.4 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
7.9.6 Yantai Dongcheng Pharmaceutical Competitive Strengths & Weaknesses
7.10 Jubilant Life Sciences
7.10.1 Jubilant Life Sciences Details
7.10.2 Jubilant Life Sciences Major Business
7.10.3 Jubilant Life Sciences Cardiology Radiopharmaceuticals Product and Services
7.10.4 Jubilant Life Sciences Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Jubilant Life Sciences Recent Developments/Updates
7.10.6 Jubilant Life Sciences Competitive Strengths & Weaknesses
7.11 Bracco
7.11.1 Bracco Details
7.11.2 Bracco Major Business
7.11.3 Bracco Cardiology Radiopharmaceuticals Product and Services
7.11.4 Bracco Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Bracco Recent Developments/Updates
7.11.6 Bracco Competitive Strengths & Weaknesses
8.1 Cardiology Radiopharmaceuticals Industry Chain
8.2 Cardiology Radiopharmaceuticals Upstream Analysis
8.3 Cardiology Radiopharmaceuticals Midstream Analysis
8.4 Cardiology Radiopharmaceuticals Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Cardiology Radiopharmaceuticals Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Cardiology Radiopharmaceuticals Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Cardiology Radiopharmaceuticals Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Cardiology Radiopharmaceuticals Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Cardiology Radiopharmaceuticals Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cardiology Radiopharmaceuticals Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Cardiology Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Cardiology Radiopharmaceuticals Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Cardiology Radiopharmaceuticals Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Cardiology Radiopharmaceuticals Players in 2023
Table 12. World Cardiology Radiopharmaceuticals Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Cardiology Radiopharmaceuticals Company Evaluation Quadrant
Table 14. Head Office of Key Cardiology Radiopharmaceuticals Player
Table 15. Cardiology Radiopharmaceuticals Market: Company Product Type Footprint
Table 16. Cardiology Radiopharmaceuticals Market: Company Product Application Footprint
Table 17. Cardiology Radiopharmaceuticals Mergers & Acquisitions Activity
Table 18. United States VS China Cardiology Radiopharmaceuticals Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Cardiology Radiopharmaceuticals Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Cardiology Radiopharmaceuticals Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cardiology Radiopharmaceuticals Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Cardiology Radiopharmaceuticals Revenue Market Share (2019-2024)
Table 23. China Based Cardiology Radiopharmaceuticals Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cardiology Radiopharmaceuticals Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Cardiology Radiopharmaceuticals Revenue Market Share (2019-2024)
Table 26. Rest of World Based Cardiology Radiopharmaceuticals Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cardiology Radiopharmaceuticals Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Cardiology Radiopharmaceuticals Revenue Market Share (2019-2024)
Table 29. World Cardiology Radiopharmaceuticals Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Cardiology Radiopharmaceuticals Market Size by Type (2019-2024) & (USD Million)
Table 31. World Cardiology Radiopharmaceuticals Market Size by Type (2025-2030) & (USD Million)
Table 32. World Cardiology Radiopharmaceuticals Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Cardiology Radiopharmaceuticals Market Size by Application (2019-2024) & (USD Million)
Table 34. World Cardiology Radiopharmaceuticals Market Size by Application (2025-2030) & (USD Million)
Table 35. GE Healthcare Basic Information, Area Served and Competitors
Table 36. GE Healthcare Major Business
Table 37. GE Healthcare Cardiology Radiopharmaceuticals Product and Services
Table 38. GE Healthcare Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. GE Healthcare Recent Developments/Updates
Table 40. GE Healthcare Competitive Strengths & Weaknesses
Table 41. Cardinal Health Basic Information, Area Served and Competitors
Table 42. Cardinal Health Major Business
Table 43. Cardinal Health Cardiology Radiopharmaceuticals Product and Services
Table 44. Cardinal Health Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Cardinal Health Recent Developments/Updates
Table 46. Cardinal Health Competitive Strengths & Weaknesses
Table 47. Curium Pharma Basic Information, Area Served and Competitors
Table 48. Curium Pharma Major Business
Table 49. Curium Pharma Cardiology Radiopharmaceuticals Product and Services
Table 50. Curium Pharma Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Curium Pharma Recent Developments/Updates
Table 52. Curium Pharma Competitive Strengths & Weaknesses
Table 53. Lantheus Medical Imaging, Inc. Basic Information, Area Served and Competitors
Table 54. Lantheus Medical Imaging, Inc. Major Business
Table 55. Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Product and Services
Table 56. Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Lantheus Medical Imaging, Inc. Recent Developments/Updates
Table 58. Lantheus Medical Imaging, Inc. Competitive Strengths & Weaknesses
Table 59. Eczacıbaşı Monrol Nuclear Products Basic Information, Area Served and Competitors
Table 60. Eczacıbaşı Monrol Nuclear Products Major Business
Table 61. Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Product and Services
Table 62. Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Eczacıbaşı Monrol Nuclear Products Recent Developments/Updates
Table 64. Eczacıbaşı Monrol Nuclear Products Competitive Strengths & Weaknesses
Table 65. Novartis International AG Basic Information, Area Served and Competitors
Table 66. Novartis International AG Major Business
Table 67. Novartis International AG Cardiology Radiopharmaceuticals Product and Services
Table 68. Novartis International AG Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Novartis International AG Recent Developments/Updates
Table 70. Novartis International AG Competitive Strengths & Weaknesses
Table 71. Siemens Basic Information, Area Served and Competitors
Table 72. Siemens Major Business
Table 73. Siemens Cardiology Radiopharmaceuticals Product and Services
Table 74. Siemens Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Siemens Recent Developments/Updates
Table 76. Siemens Competitive Strengths & Weaknesses
Table 77. China Isotope & Radiation Basic Information, Area Served and Competitors
Table 78. China Isotope & Radiation Major Business
Table 79. China Isotope & Radiation Cardiology Radiopharmaceuticals Product and Services
Table 80. China Isotope & Radiation Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. China Isotope & Radiation Recent Developments/Updates
Table 82. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 83. Yantai Dongcheng Pharmaceutical Basic Information, Area Served and Competitors
Table 84. Yantai Dongcheng Pharmaceutical Major Business
Table 85. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product and Services
Table 86. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
Table 88. Yantai Dongcheng Pharmaceutical Competitive Strengths & Weaknesses
Table 89. Jubilant Life Sciences Basic Information, Area Served and Competitors
Table 90. Jubilant Life Sciences Major Business
Table 91. Jubilant Life Sciences Cardiology Radiopharmaceuticals Product and Services
Table 92. Jubilant Life Sciences Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Jubilant Life Sciences Recent Developments/Updates
Table 94. Bracco Basic Information, Area Served and Competitors
Table 95. Bracco Major Business
Table 96. Bracco Cardiology Radiopharmaceuticals Product and Services
Table 97. Bracco Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 98. Global Key Players of Cardiology Radiopharmaceuticals Upstream (Raw Materials)
Table 99. Cardiology Radiopharmaceuticals Typical Customers
List of Figure
Figure 1. Cardiology Radiopharmaceuticals Picture
Figure 2. World Cardiology Radiopharmaceuticals Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Cardiology Radiopharmaceuticals Total Market Size (2019-2030) & (USD Million)
Figure 4. World Cardiology Radiopharmaceuticals Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Cardiology Radiopharmaceuticals Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Cardiology Radiopharmaceuticals Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Cardiology Radiopharmaceuticals Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Cardiology Radiopharmaceuticals Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Cardiology Radiopharmaceuticals Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Cardiology Radiopharmaceuticals Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Cardiology Radiopharmaceuticals Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Cardiology Radiopharmaceuticals Revenue (2019-2030) & (USD Million)
Figure 13. Cardiology Radiopharmaceuticals Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cardiology Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 16. World Cardiology Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Cardiology Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 18. China Cardiology Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Cardiology Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Cardiology Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Cardiology Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Cardiology Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 23. India Cardiology Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Cardiology Radiopharmaceuticals by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cardiology Radiopharmaceuticals Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cardiology Radiopharmaceuticals Markets in 2023
Figure 27. United States VS China: Cardiology Radiopharmaceuticals Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Cardiology Radiopharmaceuticals Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Cardiology Radiopharmaceuticals Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Cardiology Radiopharmaceuticals Market Size Market Share by Type in 2023
Figure 31. Technetium-99
Figure 32. Fluorine-18
Figure 33. Gallium-67
Figure 34. Others
Figure 35. World Cardiology Radiopharmaceuticals Market Size Market Share by Type (2019-2030)
Figure 36. World Cardiology Radiopharmaceuticals Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 37. World Cardiology Radiopharmaceuticals Market Size Market Share by Application in 2023
Figure 38. Therapeutic Use
Figure 39. Diagnostic Use
Figure 40. Cardiology Radiopharmaceuticals Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
GE Healthcare Cardinal Health Curium Pharma Lantheus Medical Imaging, Inc. Eczacıbaşı Monrol Nuclear Products Novartis International AG Siemens China Isotope & Radiation Yantai Dongcheng Pharmaceutical Jubilant Life Sciences Bracco
Related Reports
04 Jul 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
